Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

Clinical trial NCT05901545 · RECRUITING

Trial details

NCT number: NCT05901545
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Recurrent Head and Neck Squamous Cell Carcinoma

Start date: 2023-08-22
Primary completion: 2028-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.